Nonhepatosplenic extramedullary manifestations of chronic myelomonocytic leukemia: clinical, molecular and prognostic correlates

Click to increase image sizeClick to decrease image size

Acknowledgments

Current publication is supported in part by grants from the ‘The Gerstner Family Career Development Award and the Mayo Clinic Center for Individualized Medicine, Mayo Clinic, Rochester, MN, USA’.

This publication was supported by CTSA Grant Number KL2 TR000136 from the National Center for Advancing Translational Science (NCATS). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.

Potential conflict of interest

Disclosure forms provided by the authors are available with the full text of this article online at https://doi.org/10.1080/10428194.2018.1452212.